• News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Celebrities and Cancer
  • Immune Oncology
  • Breast Oncology
  • Gastrointestinal Oncology
  • Lung Oncology
  • Hematology
  • Radiotherapy
  • Cancer Types
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • Yvonne Award 2025
Double Left Left Jul / 2026 Right Double Right
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Jun    
OncodailyJournal CancerWorld OncoDaily IO OncoDaily GI Hemostasis Today Fertility News
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

ASCO Updates Breast Cancer Follow-Up Guidelines With Risk-Based Surveillance Approach

RICE Study: Can Immune Checkpoint Inhibitors Be Used Again After Progression?

Vincent Rajkumar: Limited Duration of Lenalidomide Maintenance is Just as Good as Indefinite Therapy

The System Behind Access of New Cancer Drugs | Lisa Thompson Smith

Durvalumab With Radiation Shows Promise in Chemotherapy-Ineligible Locally Advanced NSCLC

Lovett Evan Reddick: Honored to Join GSK as Executive Director, Emerging Therapeutic Areas

The Thirteen-Minute Infusion: What Sarclisa's Wearable Injector Signals for Cancer Care

Tucatinib Plus Trastuzumab Deruxtecan Shows Activity but No Clear Added Benefit in HER2+ Advanced Breast Cancer

OncoCalendar

2 events found.

Cvent

« All Events
Website https://www.cvent.com/

Events from this organizer

Today
  • February 2025

  • Mon 17
    Frontiers Symposium on Transformation in Cancer Care Delivery

    Frontiers Symposium on Transformation in Cancer Care Delivery

    Feb 17, 2025 • 4:00 PM - Feb 19, 2025 • 4:00 PM
    Salt Lake Marriott Downtown at City Creek 75 South West Temple Street, Salt Lake City, Utah, United States

    Frontiers Symposium on Transformation in Cancer Care Delivery will be held from February 17-19, 2025 at the Marriott Downtown City Creek in Salt Lake City, Utah. This Symposium will convene leaders, innovators, and practitioners from across the oncology field. This premier event will spotlight emerging models in cancer care that address the entire patient continuum—from […]

  • March 2025

  • Thu 20
    The Masters in Therapeutic Oncology Summit - Genitourinary Edition

    The Masters in Therapeutic Oncology Summit – Genitourinary Edition

    Mar 20, 2025 • 12:00 AM - Mar 23, 2025 • 12:00 AM
    The Ballantyne Hotel, Charlotte Ballantyne Commons Parkway Charlotte, Charlotte, United States

    The Masters in Therapeutic Oncology Summit - Genitourinary (GU) Edition (MaTOS-GU) will be held from March 20-23, 2025 at The Ballantyne, Charlotte. The Masters in Therapeutic Oncology Summit – Genitourinary (GU) Edition (MaTOS-GU) is a groundbreaking event designed to address the evolving challenges in the treatment of GU tumors. This summit brings together key opinion […]

  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

LinkedIn X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat
Oncology OncoDaily cancer Breast Cancer ASCO fight against cancer cancer care Global fight against cancer Lung cancer Cancer research Headlines ESMO immunotherapy NSCLC cancer treatment MD Anderson Cancer Center cancer awareness colorectal cancer clinical trials Research Childhood Cancer prostate cancer FDA ASCO24 AACR UICC Dana-Farber Cancer Institute chemotherapy Pancreatic Cancer American Cancer Society SIOP European Cancer Organisation radiation oncology Robert Orlowski American Society of Clinical Oncology Myeloma Paper of the Day AI Paolo Tarantino NCI National Cancer Institute Vivek Subbiah Myeloma WHO cervical cancer IASLC radiotherapy healthcare Memorial Sloan Kettering Cancer Center bladder cancer multiple myeloma

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}